Absci (ABSI) Cash from Financing Activities (2020 - 2026)

Absci's (ABSI) quarterly Cash from Financing Activities came in at $7.6 million in Q1 2026, down 82.34% year-on-year from $42.8 million in Q1 2025, and up 96.67% quarter-over-quarter from $3.8 million in Q4 2025.

Absci (ABSI) Cash from Financing Activities (2020 - 2026) Analysis & Trends

Absci has disclosed Cash from Financing Activities across 7 years of filings, most recently posting $7.6 million for Q1 2026.

  • Cash from Financing Activities for Q1 2026 came in at $7.6 million, down 82.34% year-over-year; the trailing twelve-month figure through Mar 2026 was $70.7 million (up 60.21% YoY), and the FY2025 annual result was $105.9 million, up 28.38% from the prior year.
  • Cash from Financing Activities came in at $7.6 million for Q1 2026 at Absci, up from $3.8 million in the prior quarter.
  • In the past five years, Cash from Financing Activities ranged from a high of $81.2 million in Q1 2024 to a low of -$1.2 million in Q4 2023.
  • The 5-year median for Cash from Financing Activities is $490000.0 (2024), against an average of $11.6 million.
  • Peak annual rise in Cash from Financing Activities reached 12209.59% in 2025, while the deepest fall reached 649.25% in 2025.
  • Absci's Cash from Financing Activities stood at $1.4 million in 2022, then slumped by 188.66% to -$1.2 million in 2023, then jumped by 179.84% to $986000.0 in 2024, then jumped by 289.66% to $3.8 million in 2025, then surged by 96.67% to $7.6 million in 2026.
  • The last three Cash from Financing Activities figures came in at $7.6 million (Q1 2026), $3.8 million (Q4 2025), and $60.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - 7.00 Mn
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn -600,000.00
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - 53,000.00
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn -538.80 Mn
9 Abivax 91.96 Bn 91.96 Bn - 85,464.43
10 Absci 1.13 Bn 1.01 Bn - 7.56 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 7.56 Mn
Mar 31, 2026 7.56 Mn
Dec 31, 2025 3.84 Mn
Dec 31, 2025 3.84 Mn
Sep 30, 2025 60.32 Mn
Sep 30, 2025 60.32 Mn
Jun 30, 2025 -1.00 Mn
Jun 30, 2025 -1.00 Mn
Mar 31, 2025 42.79 Mn
Mar 31, 2025 42.79 Mn
Dec 31, 2024 986,000.00
Dec 31, 2024 986,000.00
Sep 30, 2024 490,000.00
Sep 30, 2024 490,000.00
Jun 30, 2024 -134,000.00
Jun 30, 2024 -134,000.00
Mar 31, 2024 81.18 Mn
Mar 31, 2024 81.18 Mn
Dec 31, 2023 -1.24 Mn
Dec 31, 2023 -1.24 Mn